Safety of Latanoprost Eyedrops
Not Applicable
- Conditions
- Health Condition 1: H409- Unspecified glaucoma
- Registration Number
- CTRI/2021/10/037348
- Lead Sponsor
- Aravind Eye Hospital Pondicherry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients using Latanoprost eyedrops
Exclusion Criteria
Patients using glaucoma eyedrops other than Latanoprost
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the concentration of the eyedrops at the end of 4 and 6 weeks after opening the eye bottle as compared to the baselineTimepoint: 4 and 6 weeks
- Secondary Outcome Measures
Name Time Method To assess the contamination levels at 4 and 6 weeksTimepoint: 4 and 6 weeks